Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 3
2012 1
2013 1
2015 2
2018 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacotherapy for alcohol dependence: A stratified approach.
Thompson A, Owens L, Pushpakom SP, Faizal M, Pirmohamed M. Thompson A, et al. Among authors: pushpakom sp. Pharmacol Ther. 2015 Sep;153:10-24. doi: 10.1016/j.pharmthera.2015.05.010. Epub 2015 May 16. Pharmacol Ther. 2015. PMID: 25985735 Review.
Exacerbation of hereditary warfarin resistance by azathioprine.
Pushpakom SP, Gambhir N, Latif A, Hadfield KD, Campbell S, Newman WG. Pushpakom SP, et al. Clin Appl Thromb Hemost. 2011 Jun;17(3):293-6. doi: 10.1177/1076029609356427. Epub 2010 Mar 8. Clin Appl Thromb Hemost. 2011. PMID: 20211925 Free article.
Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists.
Cuthbertson DJ, Irwin A, Gardner CJ, Daousi C, Purewal T, Furlong N, Goenka N, Thomas EL, Adams VL, Pushpakom SP, Pirmohamed M, Kemp GJ. Cuthbertson DJ, et al. Among authors: pushpakom sp. PLoS One. 2012;7(12):e50117. doi: 10.1371/journal.pone.0050117. Epub 2012 Dec 6. PLoS One. 2012. PMID: 23236362 Free PMC article.
Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy.
Pushpakom SP, Taylor C, Kolamunnage-Dona R, Spowart C, Vora J, García-Fiñana M, Kemp GJ, Whitehead J, Jaki T, Khoo S, Williamson P, Pirmohamed M. Pushpakom SP, et al. BMJ Open. 2015 Oct 15;5(10):e009566. doi: 10.1136/bmjopen-2015-009566. BMJ Open. 2015. PMID: 26474943 Free PMC article. Clinical Trial.